Chris Male

The speaker's entire thesis centers on using technology (AI, diagnostics, virtual care) to subtype autism, deliver precision care, and create scalable service models to address a trillion-dollar market in behavioral/complex chronic health. The private sector is leading innovation where government cannot, and proven exits from Fund I demonstrate that market-rate returns are possible by applying technology to this massive, underserved health sector. The convergence of health needs, technological capability, and increasing private capital creates a compelling, long-term investment tailwind for companies innovating in this specific health tech niche. Regulatory hurdles in healthcare, slower-than-expected adoption of new care models, and potential compression of reimbursement rates.